Advertisement
U.S. Markets closed

Sprint Bioscience AB (publ) (SPRINT.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
1.7600-0.0200 (-1.12%)
At close: 05:03PM CEST

Sprint Bioscience AB (publ)

Novum
Floor 8 Hälsovägen 7 elevator A
Huddinge 141 57
Sweden
46 84 11 44 55
https://www.sprintbioscience.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 36

Key Executives

NameTitlePayExercisedYear Born
Mr. Johan EmilssonChief Executive Officer1.68MN/A1984
Prof. Pär NordlundFounder25kN/A1958
Dr. Martin AnderssonCo-Founder & Chief Scientific OfficerN/AN/A1971
Dr. Kenth HallbergFounder & Director of Structural ChemistryN/AN/A1971
Mr. Mathias SkalmstadChief Financial OfficerN/AN/A1973
Ms. Anne-Marie WenthzelChief Business OfficerN/AN/A1964
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. It develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism, nash, and diabetes. Sprint Bioscience AB (publ) was incorporated in 2009 and is based in Huddinge, Sweden.

Corporate Governance

Sprint Bioscience AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.